KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Holders of 5% or more of KALV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of KalVista Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Capital World Investors | 13G/A | 6.40%3.18M shares | – | Nov 13, 20242 filings | May 13, 2025 | SEC |
| Silverarc Capital Management, LLC | 13G | 5.60%2.88M shares | New | May 13, 20261 filing | May 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
79 Schedule 13D and 13G filings on KalVista Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:51 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 0.00%0 shares | −10.10 ppfrom 10.10%Below 5% | Jun 30, 2026 | SEC |
| Aug 14, 20264:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 0.00%0 shares | −9.90 ppfrom 9.90%Below 5% | Jun 30, 2026 | SEC |
| Aug 14, 202612:48 PM ET | Silverarc Capital Management, LLCand 1 other | 13G/A | 0.00%0 shares | 0.00 ppfrom 0.00%Below 5% | Jun 30, 2026 | SEC |
| Aug 11, 202610:42 AM ET | Silverarc Capital Management, LLCand 1 other | 13G | 0.00%0 shares | NewBelow 5% | Jun 30, 2026 | SEC |
| Jun 10, 20265:03 PM ET | Glazer Capital, LLCand 1 other | 13G | 4.85%2.58M shares | NewBelow 5% | Jun 3, 2026 | SEC |
| May 21, 20264:46 PM ET | Frazier Life Sciences Public Fund, L.P.and 13 others | 13D/A | 2.30%1.25M shares | −4.60 ppfrom 6.90%Below 5% | May 19, 2026 | SEC |
| May 15, 20264:24 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 4.20%2.14M shares | −1.30 ppfrom 5.50%Below 5% | Mar 31, 2026 | SEC |
| May 13, 20264:40 PM ET | Silverarc Capital Management, LLCand 1 other | 13G | 5.60%2.88M shares | New | Mar 31, 2026 | SEC |
| May 1, 20265:32 PM ET | Millennium Management LLCand 3 others | 13G/A | 3.70%1.91M shares | −2.20 ppfrom 5.90%Below 5% | Mar 31, 2026 | SEC |
| Jan 13, 20266:03 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 5.50%2.78M shares | +0.60 ppfrom 4.90% | Jan 5, 2026 | SEC |
| Jan 12, 20266:34 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 4.90%2.52M shares | NewBelow 5% | Jan 5, 2026 | SEC |
| Dec 30, 20254:28 PM ET | Millennium Management LLCand 3 others | 13G/A | 5.90%2.96M shares | +0.90 ppfrom 5.00% | Dec 23, 2025 | SEC |
| Nov 14, 20254:03 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 1.50%750.0K shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 10, 20254:22 PM ET | Millennium Management LLCand 2 others | 13G | 5.00%2.53M shares | New | Nov 4, 2025 | SEC |
| Nov 4, 20255:21 PM ET | Frazier Life Sciences Public Fund, L.P.and 10 others | 13D/A | 6.90%3.47M shares | +2.10 ppfrom 4.80% | Nov 1, 2025 | SEC |
| Aug 20, 20255:20 PM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13D/A | 4.80%2.40M shares | –Below 5% | Aug 18, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 9.90%4.94M shares | – | Mar 31, 2025 | SEC |
| May 13, 202511:44 AM ET | Capital World Investors | 13G/A | 6.40%3.18M shares | – | Mar 31, 2025 | SEC |
| Feb 3, 20257:43 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 10.10%5.01M shares | – | Jan 30, 2025 | SEC |
| Nov 14, 2024 | Tang Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Vestal Point Capital, LP | 13GOld format | – | New | – | SEC |
| Nov 13, 2024 | Capital World Investors | 13GOld format | – | New | – | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Adage Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | Frazier Life Sciences Public Fund, L.P. | 13D/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Apr 1, 2024 | TCG Crossover GP I, LLC | 13D/AOld format | – | – | – | SEC |
| Feb 26, 2024 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | New | – | SEC |
| Feb 22, 2024 | Frazier Life Sciences Public Fund, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 20, 2024 | TCG Crossover GP I, LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Saturn V Capital Management LLC | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20243:26 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Dec 28, 2023 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Dec 14, 2023 | Frazier Life Sciences Public Fund, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 10, 2023 | Suvretta Capital Management, LLC | 13GOld format | – | – | – | SEC |
| Feb 14, 2023 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Vivo Capital IX, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Great Point Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13GOld format | – | – | – | SEC |
| Feb 6, 2023 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Jan 31, 2023 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
| Jan 9, 2023 | TCG Crossover GP I, LLC | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
5 notices from officers, directors and other affiliates planning to sell KalVista Pharmaceuticals, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| May 27, 20265:18 PM ET | Christopher M YeaOfficer | 33.8K | $905.2K | May 27, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 16, 20244:07 PM ET | Edward FeenerFormer officer | 14.0K | $214.2K | Jul 16, 2024 | J.P. Morgan Securities LLC | SEC |
| Jan 8, 20244:47 PM ET | Edward FeenerOfficer | 59.9K | $778.6K | Jan 8, 202410b5-1 | J.P. Morgan Securities LLC | SEC |
| Dec 27, 20235:12 PM ET | Andrew CrockettOfficer | 40.0K | $480.0K | Dec 27, 202310b5-1 | J.P. Morgan Securities LLC | SEC |
| Sep 11, 20236:05 PM ET | Cha AlbertOfficer | 18.0K | $180.0K | Sep 11, 2023 | Morgan Stanley Smith Barney LLC Executive Services | SEC |